Home > Annual Financials > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS Financial Statement Analysis
[BOM: 539730]

The Revenues of FREDUN PHARMACEUTICALS have increased by 26.75% YoY .
The Earnings Per Share (EPS) of FREDUN PHARMACEUTICALS has increased by 39.47 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

FREDUN PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 539730]

StandaloneMar2024
Mar2023
Mar2022
Mar2021
Mar2020
Revenues ₹348 Cr₹275 Cr₹224 Cr₹134 Cr₹113 Cr
Expenses ₹310 Cr₹247 Cr₹211 Cr₹125 Cr₹104 Cr
Operating Profit (Excl OI) ₹38 Cr₹28 Cr₹14 Cr₹9.35 Cr₹8.33 Cr
Other Income ₹0.92 Cr₹1.82 Cr₹1.63 Cr₹1.40 Cr₹0.52 Cr
Interest ₹14 Cr₹9.28 Cr₹4.78 Cr₹4.37 Cr₹4.48 Cr
Depreciation ₹3.80 Cr₹2.81 Cr₹2.16 Cr₹2.00 Cr₹1.88 Cr
Profit Before Tax ₹21 Cr₹18 Cr₹8.60 Cr₹3.21 Cr₹2.50 Cr
Profit After Tax ₹16 Cr₹11 Cr₹6.34 Cr₹2.02 Cr₹1.90 Cr
Earnings Per Share (Rs)₹33.25₹23.84₹14.29₹5.05₹4.77
PAT Margin (%)4.493.932.821.501.69
ROE(%)15.0313.8611.424.774.74
ROCE(%)17.1317.6413.159.5310.36
Total Debt/Equity(x)0.880.980.780.920.84

Key Financials

Market Cap : ₹ 584.8 Cr
Revenue (TTM) : ₹ 497.3 Cr
Net Profit(TTM) : ₹ 23.4 Cr
EPS (TTM) : ₹ 49.9
P/E (TTM) : 24.9

Industry Peers & Returns1W1M1Y
FREDUN PHARMACEUTICALS 2.7% 17.5% 57.5%
SUN PHARMACEUTICAL INDUSTRIES 2% 1.4% -13%
DIVIS LABORATORIES 1.3% 0.3% 10.4%
CIPLA 0.3% 1.9% -6.1%
TORRENT PHARMACEUTICALS 0% -2.3% 2.6%
DR REDDYS LABORATORIES 0.5% 6.2% -1.4%
MANKIND PHARMA 2.3% 5.9% 4.6%
ZYDUS LIFESCIENCES 0.3% 6% -7.2%
LUPIN 0.2% 4% -9.8%


FREDUN PHARMACEUTICALS Revenues
[BOM: 539730]

Y-o-Y

26.75 %

5 Yr CAGR

32.55 %

Years Revenues % Change
Mar2024 ₹348 Cr
26.75
Mar2023 ₹275 Cr
22.37
Mar2022 ₹224 Cr
67.64
Mar2021 ₹134 Cr
18.73
Mar2020 ₹113 Cr -


FREDUN PHARMACEUTICALS Operating Profit
[BOM: 539730]

Y-o-Y

36.74 %

5 Yr CAGR

46.12 %

Years Operating Profit % Change
Mar2024 ₹38 Cr
36.74
Mar2023 ₹28 Cr
99.68
Mar2022 ₹14 Cr
48.83
Mar2021 ₹9.35 Cr
12.20
Mar2020 ₹8.33 Cr -

Operating Margins
Y-o-Y

7.91 %

5 Yr CAGR

10.23 %

Years Operating Margin% % Change
Mar2024 10.91%
7.91
Mar2023 10.11%
63.06
Mar2022 6.2%
-11.17
Mar2021 6.98%
-5.55
Mar2020 7.39% -

FREDUN PHARMACEUTICALS Profit After Tax
[BOM: 539730]

Y-o-Y

44.56 %

5 Yr CAGR

69.29 %

Years Profit After Tax % Change
Mar2024 ₹16 Cr
44.56
Mar2023 ₹11 Cr
70.59
Mar2022 ₹6.34 Cr
214.39
Mar2021 ₹2.02 Cr
5.94
Mar2020 ₹1.90 Cr -

PAT Margins
Y-o-Y

14.25 %

5 Yr CAGR

27.67 %

Years PAT Margin(%) % Change
Mar2024 4.49 %
14.25
Mar2023 3.93 %
39.36
Mar2022 2.82 %
88.00
Mar2021 1.5 %
-11.24
Mar2020 1.69 % -

FREDUN PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 539730]

Y-o-Y

39.47 %

5 Yr CAGR

62.49 %

Years EPS % Change
Mar2024 ₹33
39.47
Mar2023 ₹24
66.83
Mar2022 ₹14
182.97
Mar2021 ₹5.05
5.87
Mar2020 ₹4.77 -

FREDUN PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 539730]

Y-o-Y

-2.89 %

5 Yr CAGR

13.40 %

Years ROCE % Change
Mar2024 17.13%
-2.89
Mar2023 17.64%
34.14
Mar2022 13.15%
37.99
Mar2021 9.53%
-8.01
Mar2020 10.36% -

FREDUN PHARMACEUTICALS Share Price vs Sensex

Current Share Price : ₹1,244.3
Current MarketCap: ₹ 584.8 Cr
Updated EOD on :Sep 18,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

2.7%

17.5%

57.5%

SENSEX

1.8%

2.1%

0.2%

FREDUN PHARMACEUTICALS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about FREDUN PHARMACEUTICALS Financials


How the annual revenues of FREDUN PHARMACEUTICALS have changed ?

The Revenues of FREDUN PHARMACEUTICALS have increased by 26.75% YoY .

How the Earnings per Share (EPS) of FREDUN PHARMACEUTICALS have changed?

The Earnings Per Share (EPS) of FREDUN PHARMACEUTICALS has increased by 39.47 % YoY .